Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease

doi:10.4331/wjbc.v12.i6.104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10033)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

565

WORD

201

HTML

6500

Figures (1-3)

188

Sum=7454

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

505

Download

969

Sum=1474

Publishing Process of This Article

Item

Count

Browse

385

Download

698

Sum=1083

Nov 27, 2021 (publication date) through Jul 4, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Biol Chem. Nov 27, 2021; 12(6): 104-113
Published online Nov 27, 2021. doi: 10.4331/wjbc.v12.i6.104

Full Size Figure Download Figure

Figure 3 Simplified diagrams indicating the biochemical properties of several natural products are shown. Several herbs and/or their ingredients may contribute to the neuroprotection against the progression of Alzheimer’s disease. Hammerhead represents inhibition. DPP4: Dipeptidyl-peptidase-4; GLP1: Glucagon-like peptide-1; mTOR: Mammalian/mechanistic target of rapamycin.

Citation: Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6): 104-113
URL: https://www.wjgnet.com/1949-8454/full/v12/i6/104.htm
DOI: https://dx.doi.org/10.4331/wjbc.v12.i6.104